跳至主要内容
临床试验/NCT02238587
NCT02238587Unknown不适用

The Effect of Gandoerma Spores Powder Capsules on the Post-treatment Life Quality and Immune Modulation of the Patients With Head-and-neck Cancer

Chang Bing Show Chwan Memorial Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2014年6月最近更新:
适应症

试验速览

阶段
不适用
入组人数
100
试验地点
1
主要终点
Immune modulation such as tumor necrosis factors-α or interleukin-6

研究概览

简要总结

To study the effect of Ganoderma Spores Powder Capsules on the life quality and immunity status of the patients with head-and-neck cancer after complete treatment (including surgery and / or radiotherapy and/or chemotherapy)

详细描述

Ganoderma is known to modulate immunity and improve health. However, the mechanism is not clear. We hypothesize that patients who have completed standard treatment with/without radiotherapy might require biological modifier such as Ganoderma to improve life quality and immunity status.

A total of 100 patients are randomized to study and control groups. In study group, Ganoderma Spores Powder Capsules are given to the patients for 6 weeks, In control group, only placebos are given during the same period. Then the patients in study and control groups are switched, Ganoderma Spores Powder Capsules and placebos are given for 6 weeks. The data pertaining to their Life quality are collected using Quality of Life Questionnaire after the first 6 weeks and the second 6 weeks. The immunity status is also studied at the same time.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with head-and-neck cancer after complete treatment for at least 3 months (including surgery and/or radiotherapy and/or chemotherapy)

排除标准

  • Patients with head-and-neck cancer under treatment or within 3 months after treatment

结局指标

主要结局

Immune modulation such as tumor necrosis factors-α or interleukin-6

时间窗: Change from baseline in cytokines at 6 months

Subjects will be assigned to receive placebo/Ganoderma or Ganoderma Spores Powder Capsules twice a day for 12 weeks. Peripheral blood and saliva will be collected at 3 different times: (1)baseline data: before oral intervention, (2)outcome data: at 6 and 12 weeks post-oral intervention.

次要结局

  • Life quality(Change from baseline in life quality at 6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kuender D. Yang

MD, PhD, Professor

Chang Bing Show Chwan Memorial Hospital

研究点 (1)

Loading locations...

相似试验